|
G |
Ache |
acetylcholinesterase |
|
ISO |
|
RGD |
PMID:21303225 |
RGD:5688130 |
NCBI chr12:25,042,882...25,050,608
|
|
G |
Bche |
butyrylcholinesterase |
|
ISO |
protein:increased expression:blood |
RGD |
PMID:21303225 |
RGD:5688130 |
NCBI chr 2:160,607,289...160,699,760
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
ISO IEP |
mRNA, protein:increased expression:hippocampus mRNA:decreased expression:hippocampus,cerebral cortex: |
RGD |
PMID:16141791 PMID:22683802 |
RGD:5684920, RGD:8655554 |
NCBI chr 3:116,619,633...116,670,212
|
|
G |
Cd46 |
CD46 molecule |
|
ISO |
|
RGD |
PMID:16948860 |
RGD:6483465 |
NCBI chr13:109,104,122...109,134,903
|
|
G |
Chi3l1 |
chitinase 3 like 1 |
severity |
ISO |
protein:increased secretion:cerebrospinal fluid (human) |
RGD |
PMID:11986266 |
RGD:4892662 |
NCBI chr13:45,641,802...45,649,787
|
|
G |
Crp |
C-reactive protein |
|
ISO |
protein:increased expression:serum: |
RGD |
PMID:6122844 |
RGD:9491388 |
NCBI chr13:87,694,062...87,695,978
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
|
RGD |
PMID:10430840 |
RGD:8547971 |
NCBI chr 3:174,103,474...174,111,434
|
|
G |
Ngf |
nerve growth factor |
|
IEP |
mRNA:decreased expression:hippocampus: |
RGD |
PMID:22683802 |
RGD:8655554 |
NCBI chr 2:192,589,580...192,642,971
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
|
ISO |
mRNA, protein:increased expression:hippocampus |
RGD |
PMID:16141791 |
RGD:5684920 |
NCBI chr17:5,560,558...5,875,899
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
susceptibility |
ISO |
DNA:snp:cds:p.V762A rs1136410 (human) |
RGD |
PMID:21651918 |
RGD:5683901 |
NCBI chr13:94,839,484...94,871,295
|
|
G |
S100b |
S100 calcium binding protein B |
|
ISO |
protein:increased expression:cerebrospinal fluid |
RGD |
PMID:15105355 |
RGD:5508818 |
NCBI chr20:12,372,345...12,381,159
|
|
G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
disease_progression |
ISO |
|
RGD |
PMID:16786330 |
RGD:126928126 |
NCBI chr 9:20,259,227...20,276,879
|
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
mRNA:increased expression: : |
RGD |
PMID:12781911 |
RGD:7794740 |
NCBI chr 2:171,499,189...171,504,831
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
ISO |
mRNA:increased expression: : |
RGD |
PMID:12781911 |
RGD:7794740 |
NCBI chr 5:85,161,247...85,174,882
|
|
G |
Tlr7 |
toll-like receptor 7 |
|
ISO |
mRNA:increased expression: : |
RGD |
PMID:12781911 |
RGD:7794740 |
NCBI chr X:30,644,324...30,670,796
|
|
|
G |
Fcgr2a |
Fc gamma receptor 2A |
susceptibility |
ISO |
associated with Anemia, Sickle Cell;DNA:polymorphism:cds:p.H131R(human) |
RGD |
PMID:8648541 |
RGD:11040885 |
NCBI chr13:85,813,516...85,830,269
|
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:16358960 |
RGD:11528571 |
NCBI chr10:67,503,077...67,504,875
|
|
G |
Cd40 |
CD40 molecule |
|
ISO |
protein:increased expression:cerebrospinal fluid (human) |
RGD |
PMID:16463218 |
RGD:11352252 |
NCBI chr 3:174,209,113...174,224,592
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
protein:increased expression:cerebrospinal fluid (human) |
RGD |
PMID:16463218 |
RGD:11352252 |
NCBI chr X:140,164,341...140,176,057
|
|
G |
Il1b |
interleukin 1 beta |
|
IDA |
|
RGD |
PMID:23134838 |
RGD:7193053 |
NCBI chr 3:137,030,200...137,036,581
|
|
|
G |
Il4r |
interleukin 4 receptor |
|
ISO |
protein:decreased expression:serum |
RGD |
PMID:21251883 |
RGD:5128510 |
NCBI chr 1:180,115,061...180,139,981
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
|
RGD |
PMID:10318940 |
RGD:10449456 |
NCBI chr20:3,626,685...3,629,303
|
|
|
G |
C9 |
complement C9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9570574 |
|
NCBI chr 2:57,300,510...57,348,759
|
|
G |
Cd46 |
CD46 molecule |
|
ISO |
|
RGD |
PMID:12869763 |
RGD:6483466 |
NCBI chr13:109,104,122...109,134,903
|
|
G |
Cfp |
complement factor properdin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8530058 PMID:10909851 |
|
NCBI chr X:1,162,014...1,167,576
|
|
G |
Marco |
macrophage receptor with collagenous structure |
|
IEP |
protein:increased expression:sub-cortical, meninges, astrocyte |
RGD |
PMID:21299846 |
RGD:41412190 |
NCBI chr13:31,616,278...31,648,521
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
|
IEP |
|
RGD |
PMID:10430840 |
RGD:8547971 |
NCBI chr 8:4,497,960...4,508,239
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
IEP |
|
RGD |
PMID:10430840 |
RGD:8547971 |
NCBI chr 3:174,103,474...174,111,434
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
susceptibility |
ISO |
DNA:SNP,haplotype: :SNP8(human) |
RGD |
PMID:23691182 |
RGD:7800668 |
NCBI chr19:34,555,832...34,596,281
|
|
G |
Slc11a1 |
solute carrier family 11 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16597321 |
|
NCBI chr 9:75,957,193...75,968,115
|
|
G |
Tlr2 |
toll-like receptor 2 |
susceptibility |
ISO |
DNA:haplotype: :2477G>A(rs5743708)(human) |
RGD |
PMID:23691182 |
RGD:7800668 |
NCBI chr 2:171,499,189...171,504,831
|
|
G |
Tlr4 |
toll-like receptor 4 |
susceptibility |
ISO |
DNA:SNP,haplotype: :896A>G(rs4986790)(human) |
RGD |
PMID:23691182 |
RGD:7800668 |
NCBI chr 5:85,161,247...85,174,882
|
|
|
G |
Nefl |
neurofilament light chain |
disease_progression |
ISO |
protein:increased expression:CSF (human) |
RGD |
PMID:32117023 |
RGD:127285386 |
NCBI chr15:46,477,330...46,481,203
|
|
G |
Trem2 |
triggering receptor expressed on myeloid cells 2 |
disease_progression |
ISO |
protein:increased expression:CSF (human) |
RGD |
PMID:32117023 |
RGD:127285386 |
NCBI chr 9:12,647,605...12,654,190
|
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
treatment |
IMP |
|
RGD |
PMID:24491581 |
RGD:13703038 |
NCBI chr 6:40,872,936...40,920,700
|
|
G |
Aqp4 |
aquaporin 4 |
treatment |
ISO |
protein:increased expression:brain: |
RGD |
PMID:15695511 PMID:15695511 |
RGD:8698660, RGD:8698660 |
NCBI chr18:6,782,389...6,799,034
|
|
G |
Atm |
ATM serine/threonine kinase |
ameliorates |
ISO |
|
RGD |
PMID:15529270 |
RGD:126781748 |
NCBI chr 8:62,724,939...62,829,040
|
|
G |
Camp |
cathelicidin antimicrobial peptide |
|
IEP |
protein:increased expression:brain, coronal section (rat) |
RGD |
PMID:19879657 |
RGD:2316237 |
NCBI chr 8:109,841,729...109,843,543
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
IEP |
|
RGD |
PMID:21109308 |
RGD:5134982 |
NCBI chr14:17,477,542...17,479,321
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
disease_progression |
IEP |
mRNA, protein:increased expression:brain (rat) |
RGD |
PMID:31933824 |
RGD:40903068 |
NCBI chr X:75,734,281...75,762,873
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
IEP |
mRNA, protein:increased expression:brain (rat) |
RGD |
PMID:31933824 |
RGD:40903068 |
NCBI chr15:48,189,476...48,228,750
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
treatment |
ISO |
|
RGD |
PMID:24844751 |
RGD:39939118 |
NCBI chr16:74,133,259...74,145,328
|
|
G |
Il6 |
interleukin 6 |
treatment |
IEP IDA IMP |
protein:increased expression:brain |
RGD |
PMID:25443778 PMID:8943431 PMID:11581077 |
RGD:9831197, RGD:11062107, RGD:11060264 |
NCBI chr 4:5,889,999...5,894,575
|
|
G |
Lgals3 |
galectin 3 |
|
IEP |
mRNA, protein:increased expression:brain |
RGD |
PMID:17706429 |
RGD:9685206 |
NCBI chr15:20,620,083...20,632,019
|
|
G |
Lgals9 |
galectin 9 |
|
IEP |
|
RGD |
PMID:17706429 |
RGD:9685206 |
NCBI chr10:64,405,044...64,428,249
|
|
G |
Marco |
macrophage receptor with collagenous structure |
|
IEP |
protein:increased expression:meninges, astrocyte |
RGD |
PMID:21299846 |
RGD:41412190 |
NCBI chr13:31,616,278...31,648,521
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
treatment |
IMP |
|
RGD |
PMID:24419461 |
RGD:8657111 |
NCBI chr19:30,327,643...30,355,856
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
treatment |
IEP IMP |
protein:increased expression:cerebrospinal fluid |
RGD |
PMID:17371820 PMID:24419461 |
RGD:1642043, RGD:8657111 |
NCBI chr 3:174,103,474...174,111,434
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
ISO |
mRNA, protein:increased expression:brain |
RGD |
PMID:25443778 |
RGD:9831197 |
NCBI chr19:34,555,832...34,596,281
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:21603940 |
RGD:5684913 |
NCBI chr17:5,560,558...5,875,899
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
IEP |
protein:increased expression:brain, nucleus |
RGD |
PMID:25443778 |
RGD:9831197 |
NCBI chr 1:212,354,336...212,364,815
|
|
G |
Serping1 |
serpin family G member 1 |
treatment |
ISO |
|
RGD |
PMID:17538891 |
RGD:8661645 |
NCBI chr 3:90,249,410...90,259,299
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
mRNA:increased expression: : |
RGD |
PMID:12781911 |
RGD:7794740 |
NCBI chr 2:171,499,189...171,504,831
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
ISO |
mRNA:increased expression: : |
RGD |
PMID:12781911 |
RGD:7794740 |
NCBI chr 5:85,161,247...85,174,882
|
|
G |
Tlr9 |
toll-like receptor 9 |
|
ISO |
mRNA:increased expression: : |
RGD |
PMID:12781911 |
RGD:7794740 |
NCBI chr 8:115,743,407...115,747,523
|
|
G |
Tnf |
tumor necrosis factor |
disease_progression |
IEP |
protein:increased expression:brain mRNA:increased expression:brain (rat) |
RGD |
PMID:25443778 PMID:31933824 |
RGD:9831197, RGD:40903068 |
NCBI chr20:3,626,685...3,629,303
|
|
|
G |
Mir146a |
microRNA 146a |
|
IEP |
miRNA:decreased expression:brain (rat) |
RGD |
PMID:26155141 |
RGD:126925169 |
NCBI chr10:28,349,996...28,350,090
|
|
G |
Poldip2 |
DNA polymerase delta interacting protein 2 |
treatment |
ISO |
|
RGD |
PMID:32790044 |
RGD:124713556 |
NCBI chr10:63,407,237...63,417,605
|
|